Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed attachment file name title question first answered answering member label
tabling member	label

Search

1084391

registered interest
date	08/03/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Life Expectancy: West Midlands
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what recent assessment he has made of trends in the level of life expectancy in (a) Coventry South, (b) Coventry and (c) the West Midlands since 2010.
tabling member constituency	Coventry South
tabling member printed	Mr Jim Cunningham
uin	230029
answer	answer is ministerial correction date of answer 13/03/2019 answer text <p>The Office for National Statistics data show that life expectancy at birth for males in Coventry and the West Midlands was higher in 2015-17 than in 2010-12. In Coventry it increased by 0.4 years to 78.3 years, and in the West Midlands it increased by 0.2 years to 78.8 years. Life expectancy at birth for females in Coventry and the West Midlands was also higher in 2015-17 than in 2010-12. In Coventry it increased by 0.4 years to 82.4 years, and in the West Midlands it increased by 0.1 years to 82.7 years.</p><p> </p><p>For both areas, life expectancy was higher in 2015-17 than in 2010-12, but there was some fluctuation in the trend between these two time points. Only male life expectancy at birth in the West Midlands was statistically significantly higher in 2015-17, compared with 2010-12.</p><p> </p><p>The latest life expectancy data can be viewed at the following link:</p><p> </p><p><a href="https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/healthandlifeexpectancies/datasets/lifeexpectancyatbirthandatage65bylocalareasuk" target="_blank">https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/healthandlifeexpectancies/datasets/lifeexpectancyatbirthandatage65bylocalareasuk</a></p><p> </p><p>Life expectancy figures for the parliamentary constituency of Coventry South are not available.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 13/03/2019 14:18:32 answering member 4067 label Biography information for Steve Brine
tabling member	308 label Biography information for Mr Jim Cunningham

1084394

registered interest
date	08/03/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether he will report to Parliament annually on the operation of the Voluntary Scheme for Branded Medicines Pricing and Access; and whether such reporting will extend to the operation of the statutory pricing scheme.
tabling member constituency	Newton Abbot
tabling member printed	Anne Marie Morris
uin	230052
answer	answer is ministerial correction date of answer 13/03/2019 answer text <p>The Department has agreed that the 2019 Voluntary Scheme for Branded Medicines Pricing and Access will be subject to regular six-monthly reviews and a mid-scheme review with all parties to the agreement expected to attend.</p><p> </p><p>The Department already produces quarterly reports on the operation of the voluntary and statutory schemes and this is set to continue. The relevant statutory scheme regulations require an annual review of the scheme, which will be made available to Parliament on an annual basis.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 13/03/2019 14:17:16 answering member 4067 label Biography information for Steve Brine
tabling member	4249 label Biography information for Anne Marie Morris

1084397

registered interest
date	08/03/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Voluntary Scheme for Branded Medicines Pricing and Access
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what plans are in place with respect to section 3.54 of the 2019 Voluntary Scheme for Branded Medicines Pricing and Access on UK data infrastructure.
tabling member constituency	Newton Abbot
tabling member printed	Anne Marie Morris
uin	230055
answer	answer is ministerial correction date of answer 13/03/2019 answer text <p>As set out in the Long Term Plan, the National Health Service in England is committed to improving the data infrastructure and data analytics in the NHS in both primary and secondary care over the next 10 years. This will support the improvement of the quality, safety and efficiency of NHS services, as well as providing a world class environment for clinical research. Higher quality data can also enable the NHS to improve the evidence for clinically and cost-effective medicines and support better value for medicines spend, as demonstrated by the Cancer Drugs Fund.</p><p> </p><p>Implementation of the ambitions set out in the Voluntary Scheme for Branded Medicines Pricing and Access, and the NHS Long Term Plan, will build on the work of the Global Digital Exemplars and will be supported by Digital Innovation Hubs.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 13/03/2019 14:14:15 answering member 4067 label Biography information for Steve Brine
tabling member	4249 label Biography information for Anne Marie Morris

1084398

registered interest
date	08/03/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Voluntary Scheme for Branded Medicines Pricing and Access
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that payments under the 2019 Voluntary Scheme for Branded Medicines Pricing and Access are used to increase access to medicines that are recognised by NICE as (a) cost and (b) clinically effective.
tabling member constituency	Newton Abbot
tabling member printed	Anne Marie Morris
uin	230056
answer	answer is ministerial correction date of answer 13/03/2019 answer text <p>Payments made by companies who are members of the 2019 Voluntary Scheme for Branded Medicines Pricing and Access are made to the Department. The Department then allocates the payments across the National Health Service in the United Kingdom. It is for the NHS in England and the devolved administrations to make decisions in the best interest of their patients to ensure access to the medicines they need.</p><p> </p><p>NHS commissioners are legally required to make funding available for drugs and other treatments recommended in National Institute for Health and Care Excellence (NICE) technology appraisal and highly specialised technologies guidance, normally within three months of the publication of final guidance. This is reflected in the NHS Constitution as a right to NICE approved treatments.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 13/03/2019 14:15:54 answering member 4067 label Biography information for Steve Brine
tabling member	4249 label Biography information for Anne Marie Morris

1084454

registered interest
date	08/03/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Haemophilia
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what data the Government collects on the number of bleeds people with severe haemophilia have each year.
tabling member constituency	Kingston upon Hull North
tabling member printed	Diana Johnson
uin	230073
answer	answer is ministerial correction date of answer 13/03/2019 answer text <p>The United Kingdom Haemophilia Centre Doctors’ Organisation is required by the Department of Health and Social Care to collect data on diagnosis, management and complications of bleeding disorders including number of bleeds. This information is kept in the National Haemophilia Database (NHD) and funded by NHS England. The dataset can be found on the NHD website at the following link:</p><p> </p><p><a href="http://www.ukhcdo.org/wp-content/uploads/2018/12/NHD_HT_DataSet_2018_Final.pdf" target="_blank">http://www.ukhcdo.org/wp-content/uploads/2018/12/NHD_HT_DataSet_2018_Final.pdf</a></p> answering member constituency Winchester answering member printed Steve Brine question first answered 13/03/2019 14:13:13 answering member 4067 label Biography information for Steve Brine
tabling member	1533 label Biography information for Dame Diana Johnson

1084467

registered interest
date	08/03/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Radiotherapy
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many Linear Accelerator machines NHS England purchased as a result of the £130 million funding allocated to the Linear Accelerator programme in (a) 2016-17, (b) 2017-18 and (c) 2018-19; and how many machines it plans to purchase in (i) 2019-20 and (ii) 2020-21 as a result of that programme.
tabling member constituency	Westmorland and Lonsdale
tabling member printed	Tim Farron
uin	230081
answer	answer is ministerial correction date of answer 13/03/2019 answer text <p>Since October 2016, the Radiotherapy Modernisation Programme has funded over 80 replacement or upgraded Linear Accelerators (LINACs) and additional networking capability. The breakdown of equipment funded is as follows:</p><p>- 2016/17 – 18 replacement LINACs and 12 upgrades;</p><p>- 2017/18 – 26 replacement LINACs; and</p><p>- 2018/19 – 25 replacement LINACs, one upgrade and seven treatment planning systems.</p><p> </p><p>Decisions on further funding in future years have not yet been taken and will depend partly on the outcome of the Spending Review later this year.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 13/03/2019 14:11:35 answering member 4067 label Biography information for Steve Brine
tabling member	1591 label Biography information for Tim Farron

1082117

registered interest
date	05/03/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Medical Treatments: Prices
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what recent steps has he taken to ensure that medicines developed from public research are (a) accessible and (b) affordable.
tabling member constituency	Crewe and Nantwich
tabling member printed	Laura Smith
uin	228673
answer	answer is ministerial correction date of answer 13/03/2019 answer text <p>The National Institute for Health Research (NIHR) provides support for the development of new drugs, medical devices, diagnostics and treatments, primarily through its investment in research infrastructure in the National Health Service and through a range of research funding programmes. NIHR-supported research supports the early translational and clinical development of new medicines and generates high quality evidence which is made available to inform decisions about the NHS and patients on the effectiveness and cost-effectiveness of medicines, including through National Institute for Health and Care Excellence (NICE) guidance.</p><p> </p><p>NICE technology appraisal guidance, and the associated funding requirement, play an important role in ensuring that patients have access to cost-effective new medicines, including medicines developed from public research. NICE assesses important new medicines through a robust evaluation process.</p><p> </p><p>The Accelerated Access Review made recommendations to get transformative drugs and treatments to patients faster, while ensuring that the NHS gets value for money and remains at the forefront of innovation.</p><p> </p><p>We have also formed the Accelerated Access Collaborative to accelerate patient access to high performing innovations that meet NHS needs.</p><p> </p><p>The NHS is required by law to ensure that medicines recommended by NICE are routinely funded within three months, ensuring patient access to cost-effective medicines in England. There is no explicit link between the terms of NIHR research grants and the price the NHS pays for medicines.</p><p> </p><p>The Department ensures that branded medicines remain affordable to the NHS through two pricing schemes. One is the 2019 Voluntary Scheme for Branded Medicines Pricing and Access (2019 Voluntary Scheme) and the other is the statutory scheme set out in legislation.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 13/03/2019 12:28:25 answering member 4067 label Biography information for Steve Brine
tabling member	4648 label Biography information for Laura Smith

1082124

registered interest
date	05/03/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Horses: Slaughterhouses
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 10 October 2018 to Question 174614 on Horses: Slaughterhouses, how many soliped and equidae were slaughtered in 2018; and how many of those soliped and equidae carried passports issued by Weatherbys.
tabling member constituency	Birmingham, Hall Green
tabling member printed	Mr Roger Godsiff
uin	228545
answer	answer is ministerial correction date of answer 13/03/2019 answer text <p>The Food Standards Agency (FSA) is responsible for the delivery of official controls in approved meat establishments (slaughterhouses, cutting plants and game handling establishments) subject to veterinary control within the United Kingdom. The FSA records the number of soliped and equidae that are slaughtered.</p><p> </p><p>In 2018 2,618 soliped and equidae were slaughtered in FSA approved premises, of which 447 had passports issued by Weatherbys. It should be noted that Weatherbys passport numbers include Weatherbys, Weatherbys Thoroughbred, Weatherbys Ireland and Weatherbys Irish.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 13/03/2019 12:29:20 answering member 4067 label Biography information for Steve Brine
tabling member	304 label Biography information for Mr Roger Godsiff

1082309

registered interest
date	05/03/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Obesity: Children
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many children aged (a) four to five and (b) 10 to 11 years were recorded as obese in (i) England, (ii) each English region and (iii) each London borough in each year since 2010-11.
tabling member constituency	Leicester South
tabling member printed	Jonathan Ashworth
uin	228739
answer	answer is ministerial correction date of answer 13/03/2019 answer text <p><strong></strong>Data on the number of children recorded as obese in England, each region and each London Borough aged four to five years and aged 10 to 11 years, are attached.</p> answering member constituency Winchester answering member printed Steve Brine attachment 1 file name Table 1_Number of children aged 4-5 years measured in the National Child Measurement Programme (NCMP) in the obese category.docx title PQ228739 attached table 2 file name Table 2_Number of children aged 10-11 years measured in the National Child Measurement Programme (NCMP) in the obese category.docx title PQ228739 attached table question first answered 13/03/2019 12:32:22 answering member 4067 label Biography information for Steve Brine
tabling member	4244 label Biography information for Jonathan Ashworth